申请人:Sterling Drug Inc.
公开号:US04009208A1
公开(公告)日:1977-02-22
4-(Q-O)-4'-R.sub.1 -N,N'-alkylenebis(benzamides), N,N'-alkylenebis(3,4-methylenedioxybenzamides) or N,N'-alkylenebis[4-(lower-alkoxy)benzamides], having endocrinological properties, where Q is lower-alkyl, lower-alkoxyalkyl, lower-alkenyl, halo-lower-alkyl, halo-lower-alkenyl, lower-cycloalkyl, phenyl and BN-(lower-alkyl) where BN is di-(lower-alkyl)amino or a saturated N-heteromonocyclic radical having from five to seven ring atoms and alkylene has at least five carbon atoms between its two connecting linkages and R.sub.1 is Q-O-, hydrogen, lower-alkoxy, lower-alkyl, halo, benzyloxy, hydroxy, di-(lower-alkyl)amino, nitro, amino or trihalomethyl are prepared preferably by reacting the appropriate diamine or N-(aminoalkyl)-benzamide with two or one molar equivalents, respectively, of the appropriate benzoyl halide.
4-(Q-O)-4'-R.sub.1 -N,N'-烷基双苯甲酰胺,N,N'-烷基双(3,4-二甲氧基苯甲酰胺)或N,N'-烷基双[4-(低碳氧基)苯甲酰胺],具有内分泌学特性,其中Q是低碳基,低碳氧基烷基,低碳烯基,卤代低碳基,卤代低碳烯基,低环烷基,苯基和BN-(低碳基)其中BN是二(低碳基)氨基或具有五至七个环原子的饱和N-杂环基团,烷基在其两个连接链之间至少有五个碳原子,R.sub.1是Q-O-,氢,低碳氧基,低碳基,卤素,苄氧基,羟基,二(低碳基)氨基,硝基,氨基或三卤甲基,通常通过将适当的二胺或N-(氨基烷基)-苯甲酰胺与相应的苯甲酰卤反应制备而成。